China Resources Double-Crane Pharmaceutical

China Resources Double-Crane Pharmaceutical is one of the...

• CSI 500.

China Resources Double-Crane Pharmaceutical is a company listed under the stock ticker 600062 (CN).

View the org chart displaying its 19 main executives

Most searched biographies at China Resources Double-Crane Pharmaceutical

• Wenchao Lu, Acting Chairman of the Board and President
• Shutian Yu, Director
• Cailian Kang, Director

Create your alert
to follow the executive moves at China Resources Double-Crane Pharmaceutical.

China Resources Double-Crane Pharmaceutical has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by China Resources Double-Crane Pharmaceutical

Social media about China Resources Double-Crane Pharmaceutical

• China Resources Double-Crane Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• China Resources Double-Crane Pharmaceutical on LinkedIn, Twitter & YouTube

Call China Resources Double-Crane Pharmaceutical at +86 106...

View the org chart

Register to receive your alert

Report an error